Scinnohub Pharmaceutical Co., Ltd.

This study tests an experimental drug called BT-114143 to see if it can reduce blood loss during knee replacement surgery better than the current standard treatment. About 270 adults having knee replacement will receive either a high or low dose of BT-114143 or tranexamic acid. T…

This early-stage study tests a new injection called BT-114143 for people with abnormal uterine bleeding (heavy or irregular periods). About 39 adults will receive either the drug or a placebo to check safety and how well it reduces bleeding. The goal is to find a treatment that c…